Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Court denies GSK appeal in Vectura intellectual property dispute

Fri, 20th Nov 2020 08:34

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.
The FTSE 250 company said the Court of Appeals had thus upheld the District Court of Delaware's ruling on post-trial motions.

In September 2019, the District Court issued a ruling on the parties' post-trial motions, upholding the award of $89.7m in damages to Vectura, as well as ongoing royalties of 3% on US sales of certain infringing GSK 'Ellipta' products.

It also upheld supplemental damages based on GSK's infringing sales of around $10.5m, and pre-judgment interest at the prime rate of about $6.7m.

GSK now had 30 days to file a petition for rehearing.

"We are very pleased with the result of this appeal, which confirms the validity of our intellectual property and the decision to progress this litigation with GSK," said chief executive officer Will Downie.

"Once we have further clarity regarding final settlement and potential timing of receipts, we will provide a further market update."

Under US civil procedure, a motion for judgement as a matter of law is a motion claiming that an opposing party has insufficient evidence to support its case.

Peel Hunt noted that Vectura had previously estimated that damages with interest and accumulated interest could amount to around $200m, although the precise amount would depend on GSK reporting the sales of the infringing products.

"We updated our model in May 2019 to include the $89.7m damages awarded over the Ellipta product suite," the investment bank said.

"The overall impact of the litigation payments - which we treated as a one-off lump sum exceptional payment at the time for simplicity - was to add £110m to Vectura's cash on the balance sheet."

At 0855 GMT, shares in Vectura were up 4.62% at 122.2p.
More News
1 Oct 2021 10:22

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

IN BRIEF: Philip Morris deal for Vectura gets 97% acceptances

Read more
29 Sep 2021 09:23

UPDATE 2-Morrisons takeover battle will go to UK auction on Oct. 2

(Adds background)LONDON, Sept 29 (Reuters) - A $9.5-billion fight for British supermarket Morrisons will be decided at an auction on Saturday, when two U.S. private equity groups will go head-to-head in up to five rounds of bids.Britain's Takeover...

Read more
20 Sep 2021 13:35

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

IN BRIEF: Vectura to delist on October 19 after Philip Morris takeover

Read more
16 Sep 2021 11:29

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

TOP NEWS SUMMARY: Tobacco maker Philip Morris wins asthma firm Vectura

Read more
16 Sep 2021 09:07

TOP NEWS: Vectura shareholders accept Philip Morris takeover

TOP NEWS: Vectura shareholders accept Philip Morris takeover

Read more
16 Sep 2021 08:02

Philip Morris seals contentious Vectura takeover

(Sharecast News) - Philip Morris International has taken control of Vectura after the cigarette company's contentious bid was supported by owners of almost 75% of the inhaler maker's shares.

Read more
16 Sep 2021 07:33

UPDATE 3-Philip Morris seals deal for UK's Vectura despite health group concerns

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds comment from health group; background on deal)By Pushkala Aripaka and Siddh...

Read more
16 Sep 2021 07:33

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

* Holders of roughly 75% Vectura shares tender support* PMI needed 50% backing for deal to go through* Extends deadline for other holders to tender shares by Sept. 30 (Adds detail, background)By Pushkala AripakaSept 16 (Reuters) - Cigarette maker P...

Read more
14 Sep 2021 18:24

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

IN BRIEF: Philip Morris gets Japanese regulatory approval for Vectura

Read more
8 Sep 2021 07:49

UPDATE 3-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds detail, shares)By James DaveyLONDON, Sept 8 (...

Read more
8 Sep 2021 07:49

UPDATE 2-$10 bln U.S. battle for Britain's Morrisons heads for auction

* Morrisons agreed CD&R's 7 bln stg offer last month* Rival suitor Fortress considering options* All parties talking to Takeover Panel regarding auction* Morrisons shares trading above CD&R's offer (Adds details, shares)By James DaveyLONDON, Sept 8 ...

Read more
8 Sep 2021 07:28

UPDATE 2-UK's Smiths to sell medical division to ICU for $2.4 bln, snubs TA

* Smiths Group agrees sale of unit to ICU Medical* Withdraws recommendation for TA Associates deal* Shares up 4%, biggest riser on the FTSE 100 index (Adds shares, ICU Medical statement, background)By Yadarisa ShabongSept 8 (Reuters) - British indus...

Read more
19 Aug 2021 14:32

Philip Morris snaps up more Vectura shares ahead of deal deadline

(Sharecast News) - US tobacco giant Philip Morris has bought up more shares of London-listed inhaler maker Vectura.

Read more
19 Aug 2021 10:47

Philip Morris lifts Vectura stake to 29%, halts further market trades

Philip Morris lifts Vectura stake to 29%, halts further market trades

Read more
18 Aug 2021 10:27

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Philip Morris buys 23% Vectura stake ahead of contentious vote on deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.